Healthcare
Healthcare robotics: Reasons why this sector will be 'explosive'
The disruptive industries of robotics, automation and artificial intelligence have come to the fore over recent years, with headlines commonplace, including driverless cars reducing road accidents, intelligent fridges doing your shopping and robots increasing...
Revealed: The strategies providing equity correction protection over 20 years
The sectors that have weathered the storm over the years
Why healthcare stocks remain attractive despite drug pricing pressure
'Unjustly punished in sell-off last year'
Ten years in the life of ETFs: From pre-teen to 2017
7IM's Peter Sleep comments on developments
Active managers' outperformance set to continue as stock correlations decline
AB Bernstein report
Ardevora's Lang: Why healthcare is not necessarily a 'safe' sector
Growth becoming harder to achieve
Beyond the FTSE 250: What are the top stock picks for H2 2017?
As revealed by Cantor Fitzgerald Europe
Baillie Gifford launches Positive Change fund run by eight-strong management team
Focused on companies making a social impact
Gallery: What are the most under-owned global stocks?
New data from UBS
When could personalised medicine move mainstream?
Scientific breakthroughs the key driver
'Often the greatest returns come in the final stages of the cycle'
Valuations remain high
First legislative victory for Trump as healthcare bill passes first hurdle
Step closer to repealing Obamacare
How to approach the 'long list of uncertainties' in US equities
'Highly selective approach'
Biotech: Forget 'Trumpcare', M&A will be biggest driver
Large acquisitions due
Update: Woodford calls for Patient Capital tax wrapper to boost small business investment
More support needed for UK innovation
Biotech trusts top performance charts in February
QuotedData monthly roundup
Investors shrug off Trump worries and keep faith with under fire healthcare sector
Criticised pricing policies
Part III: Where next for the value comeback and how are you gaining exposure?
In the third part of a short series, managers tell Investment Week which value plays still look attractive after a strong run this year.
Matthews Asia: How to invest in Asia's structural reform story
Tides change for India and China
Unpicking the risk/reward in healthcare stocks
2016 saw several blow-ups for large drug companies
Industry Voice: Sentiment does not reflect strong healthcare sector fundamentals
New products, strong finances and robust growth were the main talking points at JP Morgan's recent healthcare conference in San Francisco. There were positive signals regarding the fundraising climate, as well as the strength of innovation within the...
Part I: Where next for the value comeback and how are you gaining exposure?
Opportunities in a number of sectors
Love at first sight: Which mandates are on fund selectors' radars for 2017?
Valentine's Day special
Most read
